RedCloud Bio
PrivateLast Round
Series B
Extension
May 15, 2023
Total Funding Raised
$29.65M
Company Overview
RedCloud Bio operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B Extension round in May 2023.
RedCloud Bio is a biotechnology company that integrates structural pharmacology and computational technologies to discover and develop small molecule drugs for cancer and other severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RedCloud Bio Comparables
Compare RedCloud Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| J INTS BIO | 87% | |
| Eli Lilly and Company | 86% | |
| Black Diamond Therapeutics | 77% |
For institutional investors. Book with your work email.
RedCloud Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 15, 2023 | ||||
| Series B | Jun 17, 2021 | ||||
| Series A | Nov 30, 2019 | ||||
| Seed | Jul 1, 2018 |
For institutional investors. Book with your work email.
RedCloud Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Series B |
| Co-Win Ventures | Series B |
| Sherpa Healthcare Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 833% MoM.
- May 15, 2023
$14.15M raised in Series B Extension round.
For institutional investors. Book with your work email.
RedCloud Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RedCloud Bio's valuation, stock price, and market status.
Is RedCloud Bio a public or private company?
RedCloud Bio is a private company.
What is the current stock price of RedCloud Bio?
RedCloud Bio is a private company, so its shares have no public market price. Caplight tracks RedCloud Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RedCloud Bio worth (valuation)?
Valuation information for RedCloud Bio is not publicly available.
Can I buy RedCloud Bio stock?
RedCloud Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RedCloud Bio's last funding round?
RedCloud Bio's most recent funding round was Series B Extension on May 15, 2023.
Who are the main investors in RedCloud Bio?
Key investors in RedCloud Bio include Co-Win Ventures.
Will RedCloud Bio IPO soon?
No public IPO plans have been announced for RedCloud Bio.
How can I track RedCloud Bio secondary market activity?
Caplight tracks bids, offers, and trades in RedCloud Bio's shares on secondary markets.